TLRY: Tilray Brands, Inc. Stock

by  •  • Comments Off on TLRY: Tilray Brands, Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 1,246.54
Enterprise Value ($M) 1,368.80
Book Value ($M) 3,483.41
Book Value / Share 3.86
Price / Book 0.36
NCAV ($M) -52.57
NCAV / Share -0.06
Price / NCAV -23.71

Profitability (mra)
Return on Invested Capital (ROIC) -0.06
Return on Assets (ROA) -0.05
Return on Equity (ROE) -0.07

Liquidity (mrq)
Quick Ratio 1.57
Current Ratio 2.47

Balance Sheet (mrq) ($M)
Current Assets 725.88
Assets 4,261.87
Liabilities 778.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 788.94
Operating Income -96.33
Net Income -222.40
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -30.91
Cash from Investing 128.35
Cash from Financing -75.19

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-10-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-04-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-01-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 7,390,110 23,104,090 31.99
2024-11-14 6,829,682 20,339,891 33.58
2024-11-13 7,317,639 26,619,837 27.49
2024-11-12 13,861,496 40,986,641 33.82
2024-11-11 12,024,855 39,535,146 30.42

(click for more detail)

Similar Companies
TARS – Tarsus Pharmaceuticals, Inc. TECH – Bio-Techne Corporation
TERN – Terns Pharmaceuticals, Inc. TNYA – Tenaya Therapeutics, Inc.
TRML – Tourmaline Bio, Inc.


Financial data and stock pages provided by
Fintel.io